IJT - CIR - February 2024 - 80S

80S
International Journal of Toxicology 43(Supplement 1)
27. Johnsen MA. The Influence of particle size. Spray Technol
Mark. 2004;14(11):24-27.
28. CIR Science and Support Committee of the Personal Care
Products Council (CIR SSC). Cosmetic Powder Exposure.
Unpublished data submitted by the Personal Care Products
Council., 2015.
29. Aylott RI, Byrne GA, Middleton J, et al. Normal use levels of
respirable cosmetic talc: Preliminary study. Int J Cosmet Sci.
1976;1(3):177-186.
30. Russell RS, Merz RD, Sherman WT, et al. The determination of
respirable particles in talcum powder. Food Cosmet Toxicol.
1979;17(2):117-122.
31. European Union . Regulation (EC) No. 1223/2009 of the European
Parliament and of the Council of 30 November 2009 on
Cosmetic Products. 2009. http://eur-lex.europa.eu/LexUriServ/
LexUriServ.do?uri=OJ:L:2009:342:0059:0209:en:PDF
32. American Botanical Council. Herbal Medicine: Expanded
Commission E Monographs - Ginkgo Biloba leaf extract. 2000.
Integrative Medicine Communications.This monograph, published
by the Commission E in 1994, was modifiedbasedonnew
scientific research. It contains more extensive pharmacological
and therapeutic information taken directly from the Commission
E., 2000. http://cms.herbalgram.org/expandedE/
GinkgoBilobaleafextract.html Accessed 1-23-2018
33. Mahdy HM, Tadros MG, Mohamed MR, et al. The effect of
Ginkgo biloba extract on 3-nitropropionic acid-induced neurotoxicity
in rats. Neurochem Int. 2011;59(6):770-778.
34. Goldie M, Dolan S. Bilobalide, a unique constituent of Ginkgo
biloba, inhibits inflammatory pain in rats. Behav Pharmacol.
2013;24(4):298-306.
35. Yirmibesoglu E, Karahacioglu E, Kilic D, et al. The protective
effects ofGinkgo biloba extract (EGb-761) on radiation-induced
dermatitis: An experimental study. Clin Exp Dermatol. 2012;
37(4):387-394.
36. Amin A, Abraham C, Hamza AA, et al. A standardized
extract of Ginkgo biloba neuralizes ciplatin-mediated reproductive
toxicity in rats. JBiomed Biotechnol. 2012;2012:
1-11.
37. Ho L-J, Hung L-F, Liu F-C, et al. GIngko biloba extract individually
inhibits JNK activiation and induces c-Jun degradation
in human chondrocytes: potential therapeutics for
osteoarthritis. PLoS One. 2013;8(12):e82033.
38. Rajendran P, Rengarajan T, Nandakumar N, et al. Kaempferol, a
potential cytostatic and cure for inflammatory disorders. Eur J
Med Chem. 2014;86:103-112.
39. Lim H, Son KH, Chang HW, et al. Effects of anti-inflammatory
biflavonoid, ginkgetin, on chronic skin inflammation. Biol
Pharm Bull. 2006;29(5):1046-1049.
40. dal Belo SE, Gaspar LR, Maia Campos PMBG. Photoprotective
effects of topical formulations containing a combination of
Ginkgo biloba and green tea extracts. Phytother Res. 2011;25:
1854-1860.
41. Chen C-C, Chiang A-N, Liu H-N, et al. EBb-761 prevents
ultraviolet B-induced photoaging via inactivation of mitogenactivated
protein kinases and proinflammatory cytokine expression.
J Dermatol Sci. 2014;75:55-62.
42. Posadzki P, Watson L, Ernst E. Herb-drug interactions: An
overview of systematic reviews. Br J Clin Pharmacol. 2012;
75(3):603-618.
43. Fugh-Berman A. Herb-drug interactions. Lancet. 2000;
355(9198):134-138.
44. dal Belo SE, Gaspar LR, Maia Campos PMBG, et al. Skin
penetration of epigallocatechin-3-gallate and quercetin from
green tea and Ginkgo biloba extract vehiculated in cosmetic
formulations. Skin Pharmacol Physiol. 2009;22(6):299-304.
45. Moreau JP, Eck CR, McCabe J, et al. Absorption, distribution
and elimination of a labelled extract ofGinkgo biloba
leaves in the rat [in French, English summary]. Presse Med. 1986;
15(31):1458-1461.
46. Woelkart K, Fizlmayr E, Dittrich P, et al. Pharmacokinetics of
bilobalide, ginkgolide A and B after administration of three
different Ginkgo biloba L preparations in humans. Phytother
Res. 2010;24(3):445-450.
47. Salvador RL. Herbal medicine: ginkgo. Can Pharmacists J.
1995;52:39-41.
48. Anonymous. Ginkgo Biloba Meristem Cell: Summary of toxicity
testing. Unpublished data submitted by Personal Care
Products Council., 2017.
49. Maeda J, Kijima A, Inoue K, et al. In vivo genotoxicity of
GInkgo biloba extract in gpt delta mice and constitutive androstane
receptor knockout mice. Toxicol Sci. 2014;140(2):
298-306.
50. Koch E, N¨oldner M, Leuschner J. Reproductive and developmental
toxicity of the Ginkgo biloba special extract EGb 761 in
mice. Phytomedicine. 2013;21:90-97.
51. El Mazoudy RH, Attia AA. Efficacy ofGinkgo biloba on vaginal
estrous and ovarian histological alterations for evaluating antiimplantation
and abortifacient potentials in albino female mice.
Birth Defects Res B Dev Reprod Toxicol. 2012;95:444-459.
52. Fernandes ES, Pinto RM, de Paula Reis JE, et al. Effects of
Ginkgo biloba extract on the embryo-fetal development in
Wistar rats. Birth Defects Res B Dev Reprod Toxicol. 2010;
89(2):133-138.
53. Lin H, Guo X, Zhang S, et al. Mechanistic evaluation ofGinkgo
biloba leaf extract-induced genotoxicity in L5178Y cells.
Toxicol Sci. 2014;139(2):338-349.
54. Heinonen T, Gaus W. Cross matching observations on toxicological
and clinical data for the assessment of tolerability
and safety of Ginkgo biloba leaf extract. Toxicol. 2015;327:
95-115.
55. International Agency for Research on Cancer (IARC). Some
Drugs and Herbal Products: Ginkgo Biloba. Lyon, France:
International Agency for Research on Cancer; 2015.
56. Hausen BM. The sensitizing capacity of ginkgolic acids in
Guinea pigs. Am J Contact Dermat. 1998;9(3):146-148.
57. TKL Research Inc. Repeated insult patch test study (lotion
containing 0.2% Ginkgo Biloba LeafExtract). Unpublished data
submitted by Personal Care Products Council, 2003.
http://eur-lex.europa.eu/LexUriServ/LexUriServ.do?uri=OJ:L:2009:342:0059:0209:en:PDF http://eur-lex.europa.eu/LexUriServ/LexUriServ.do?uri=OJ:L:2009:342:0059:0209:en:PDF http://cms.herbalgram.org/expandedE/GinkgoBilobaleafextract.html http://cms.herbalgram.org/expandedE/GinkgoBilobaleafextract.html

IJT - CIR - February 2024

Table of Contents for the Digital Edition of IJT - CIR - February 2024

Contents
IJT - CIR - February 2024 - Cover1
IJT - CIR - February 2024 - Cover2
IJT - CIR - February 2024 - 1S
IJT - CIR - February 2024 - 2S
IJT - CIR - February 2024 - Contents
IJT - CIR - February 2024 - 4S
IJT - CIR - February 2024 - 5S
IJT - CIR - February 2024 - 6S
IJT - CIR - February 2024 - 7S
IJT - CIR - February 2024 - 8S
IJT - CIR - February 2024 - 9S
IJT - CIR - February 2024 - 10S
IJT - CIR - February 2024 - 11S
IJT - CIR - February 2024 - 12S
IJT - CIR - February 2024 - 13S
IJT - CIR - February 2024 - 14S
IJT - CIR - February 2024 - 15S
IJT - CIR - February 2024 - 16S
IJT - CIR - February 2024 - 17S
IJT - CIR - February 2024 - 18S
IJT - CIR - February 2024 - 19S
IJT - CIR - February 2024 - 20S
IJT - CIR - February 2024 - 21S
IJT - CIR - February 2024 - 22S
IJT - CIR - February 2024 - 23S
IJT - CIR - February 2024 - 24S
IJT - CIR - February 2024 - 25S
IJT - CIR - February 2024 - 26S
IJT - CIR - February 2024 - 27S
IJT - CIR - February 2024 - 28S
IJT - CIR - February 2024 - 29S
IJT - CIR - February 2024 - 30S
IJT - CIR - February 2024 - 31S
IJT - CIR - February 2024 - 32S
IJT - CIR - February 2024 - 33S
IJT - CIR - February 2024 - 34S
IJT - CIR - February 2024 - 35S
IJT - CIR - February 2024 - 36S
IJT - CIR - February 2024 - 37S
IJT - CIR - February 2024 - 38S
IJT - CIR - February 2024 - 39S
IJT - CIR - February 2024 - 40S
IJT - CIR - February 2024 - 41S
IJT - CIR - February 2024 - 42S
IJT - CIR - February 2024 - 43S
IJT - CIR - February 2024 - 44S
IJT - CIR - February 2024 - 45S
IJT - CIR - February 2024 - 46S
IJT - CIR - February 2024 - 47S
IJT - CIR - February 2024 - 48S
IJT - CIR - February 2024 - 49S
IJT - CIR - February 2024 - 50S
IJT - CIR - February 2024 - 51S
IJT - CIR - February 2024 - 52S
IJT - CIR - February 2024 - 53S
IJT - CIR - February 2024 - 54S
IJT - CIR - February 2024 - 55S
IJT - CIR - February 2024 - 56S
IJT - CIR - February 2024 - 57S
IJT - CIR - February 2024 - 58S
IJT - CIR - February 2024 - 59S
IJT - CIR - February 2024 - 60S
IJT - CIR - February 2024 - 61S
IJT - CIR - February 2024 - 62S
IJT - CIR - February 2024 - 63S
IJT - CIR - February 2024 - 64S
IJT - CIR - February 2024 - 65S
IJT - CIR - February 2024 - 66S
IJT - CIR - February 2024 - 67S
IJT - CIR - February 2024 - 68S
IJT - CIR - February 2024 - 69S
IJT - CIR - February 2024 - 70S
IJT - CIR - February 2024 - 71S
IJT - CIR - February 2024 - 72S
IJT - CIR - February 2024 - 73S
IJT - CIR - February 2024 - 74S
IJT - CIR - February 2024 - 75S
IJT - CIR - February 2024 - 76S
IJT - CIR - February 2024 - 77S
IJT - CIR - February 2024 - 78S
IJT - CIR - February 2024 - 79S
IJT - CIR - February 2024 - 80S
IJT - CIR - February 2024 - 81S
IJT - CIR - February 2024 - 82S
IJT - CIR - February 2024 - 83S
IJT - CIR - February 2024 - 84S
IJT - CIR - February 2024 - 85S
IJT - CIR - February 2024 - 86S
IJT - CIR - February 2024 - 87S
IJT - CIR - February 2024 - 88S
IJT - CIR - February 2024 - 89S
IJT - CIR - February 2024 - 90S
IJT - CIR - February 2024 - 91S
IJT - CIR - February 2024 - 92S
IJT - CIR - February 2024 - 93S
IJT - CIR - February 2024 - 94S
IJT - CIR - February 2024 - 95S
IJT - CIR - February 2024 - 96S
IJT - CIR - February 2024 - 97S
IJT - CIR - February 2024 - 98S
IJT - CIR - February 2024 - 99S
IJT - CIR - February 2024 - 100S
IJT - CIR - February 2024 - 101S
IJT - CIR - February 2024 - 102S
IJT - CIR - February 2024 - 103S
IJT - CIR - February 2024 - 104S
IJT - CIR - February 2024 - 105S
IJT - CIR - February 2024 - 106S
IJT - CIR - February 2024 - 107S
IJT - CIR - February 2024 - 108S
IJT - CIR - February 2024 - 109S
IJT - CIR - February 2024 - 110S
IJT - CIR - February 2024 - 111S
IJT - CIR - February 2024 - 112S
IJT - CIR - February 2024 - 113S
IJT - CIR - February 2024 - 114S
IJT - CIR - February 2024 - 115S
IJT - CIR - February 2024 - 116S
IJT - CIR - February 2024 - 117S
IJT - CIR - February 2024 - 118S
IJT - CIR - February 2024 - Cover3
IJT - CIR - February 2024 - Cover4
https://www.nxtbookmedia.com